Clinical Trials Directory

Phase 2 Trial of Response-Based Radiation Therapy for Patients With Localized Central Nervous System Germ Cell Tumors (CNS GCT)

Drugs used as chemotherapy, such as carboplatin, etoposide, and ifosfamide work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Radiation therapy uses high-energy x rays to kill tumor cells. Giving chemotherapy with radiation therapy may kill more tumor cells. This phase II trial studies how well chemotherapy and radiation therapy work in treating younger patients with newly diagnosed central nervous system germ cell tumors.

Stanford is now accepting new patients for this trial.

Investigator(s):

Intervention(s):

  • drug : carboplatin
  • drug : etoposide
  • drug : ifosfamide
  • procedure : therapeutic conventional surgery
  • radiation : 3-dimensional conformal radiation therapy
  • radiation : intensity-modulated radiation therapy

Phase: Phase 2

Eligibility

Ages Eligible For Study:

3 Years - 21 Years

External Links

Explore related trials

Contact information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Christina Baggott
650-497-7659
Recruiting

Footer Links: